Mechanisms, challenges and opportunities in stroke (original) (raw)

• Report of the Stroke Progress Review Group. (National Institute of Neurological Disorders and Stroke, Maryland) 1–116 (2002). This report from an expert panel convened by the National Institute of Neurological Disorders and Stroke (NINDS) assessed progress in stroke research and provided recommendations for priorities and directions to be emphasized for the next decade.
• Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 145–153 (2000).
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7–22 (2002).
• Yusuf, S. Two decades of progress in preventing vascular disease. Lancet 360, 2–3 (2002).
  Article PubMed Google Scholar
• Hassan, A. & Markus, H. S. Genetics and ischaemic stroke. Brain 123, 1784–1812 (2000).
  Article PubMed Google Scholar
• Ginsberg, M. D., Belayev, L., Zhao, W., Huh, P. W. & Busto, R. The acute ischemic penumbra: topography, life span, and therapeutic response. Acta Neurochir. Suppl. (Wien) 73, 45–50 (1999).
  CAS Google Scholar
• Garcia, J. H. et al. Ischemic stroke and incomplete infarction. Stroke 27, 761–765 (1996).
  Article CAS PubMed Google Scholar
• Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431–1568 (1999).
  Article CAS PubMed Google Scholar
• Shimizu-Sasamata, M., Bosque-Hamilton, P., Huang, P. L., Moskowitz, M. A. & Lo, E. H. Attenuated neurotransmitter release and spreading depression-like depolarizations after focal ischemia in mutant mice with disrupted type I nitric oxide synthase gene. J. Neurosci. 18, 9564–9571 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Cao, G. et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22, 5423–5431 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hossmann, K. A. Periinfarct depolarizations. Cerebrovasc. Brain Metab. Rev. 8, 195–208 (1996). A comprehensive review of penumbral blood flow and metabolic dynamics in focal cerebral ischaemia.
  CAS PubMed Google Scholar
• Bruno, V. et al. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab. 21, 1013–1033 (2001).
  Article CAS PubMed Google Scholar
• Michaelis, E. K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54, 369–415 (1998).
  Article CAS PubMed Google Scholar
• Pellegrini-Giampietro, D. E., Zukin, R. S., Bennett, M. V., Cho, S. & Pulsinelli, W. A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl Acad. Sci. USA 89, 10499–10503 (1992). One of the earliest demonstrations that post-ischaemic modifications in neurotransmitter receptor structure influence excitotoxic neuronal death.
  Article CAS PubMed PubMed Central Google Scholar
• Oguro, K. et al. Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons. J. Neurosci. 19, 9218–9227 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Morikawa, E. et al. Attenuation of focal ischemic brain injury in mice deficient in the ε1 (NR2A) subunit of NMDA receptor. J. Neurosci. 18, 9727–9732 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Calabresi, P. et al. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 61, 231–265 (2000).
  Article CAS PubMed Google Scholar
• Horn, J. & Limburg, M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 32, 570–576 (2001).
  Article CAS PubMed Google Scholar
• Paschen, W. Role of calcium in neuronal injury. Brain Res. Bull. 53, 409–413 (2000).
  Article CAS PubMed Google Scholar
• Zipfel, G. J., Lee, J. M. & Choi, D. W. Reducing calcium overload in ischemic brain. New Engl. J. Med. 341, 1543–1544 (1999).
  Article CAS PubMed Google Scholar
• Frederickson, C. J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31, 145–238 (1989).
  Article CAS PubMed Google Scholar
• Weiss, J. H., Hartley, D. M., Koh, J. Y. & Choi, D. W. AMPA receptor activation potentiates zinc neurotoxicity. Neuron 10, 43–49 (1993).
  Article CAS PubMed Google Scholar
• Sorensen, J. C., Mattsson, B., Andreasen, A. & Johansson, B. B. Rapid disappearance of zinc positive terminals in focal brain ischemia. Brain Res. 812, 265–269 (1998).
  Article CAS PubMed Google Scholar
• Gribkoff, V. K. et al. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nature Med. 7, 471–477 (2001).
  Article CAS PubMed Google Scholar
• Fiskum, G., Murphy, A. N. & Beal, M. F. Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab. 19, 351–369 (1999).
  Article CAS PubMed Google Scholar
• Chan, P. H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21, 2–14 (2001).
  Article CAS PubMed Google Scholar
• Murphy, A. N., Fiskum, G. & Beal, M. F. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death. J. Cereb. Blood Flow Metab. 19, 231–245 (1999).
  Article CAS PubMed Google Scholar
• Makar, T. K. et al. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45–53 (1994).
  Article CAS PubMed Google Scholar
• Kroemer, G. & Reed, J. C. Mitochondrial control of cell death. Nature Med. 6, 513–519 (2000).
  Article CAS PubMed Google Scholar
• Bernardi, P., Petronilli, V., DiLisa, F. & Forte, M. A mitochondrial perspective on cell death. Trends Biochem. Sci. 26, 112–117 (2001).
  Article CAS PubMed Google Scholar
• Fujimura, M. et al. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J. Neurosci. 19, 3414–3422 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kondo, T. et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17, 4180–4189 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kinouchi, H. et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl Acad. Sci. USA 88, 11158–11162 (1991). The first study that used transgenic mice to demonstrate the importance of oxidative stress in ischaemic brain injury.
  Article CAS PubMed PubMed Central Google Scholar
• Sheng, H. et al. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 88, 185–191 (1999).
  Article CAS PubMed Google Scholar
• Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA 87, 1620–1624 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, Z. et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883–1885 (1994). The first study using knockout mouse technology to show that the neuronal isoform of nitric oxide synthase has a detrimental role in focal stroke.
  Article CAS PubMed Google Scholar
• Iadecola, C., Zhang, F., Casey, R., Nagayama, M. & Ross, M. E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157–9164 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, J., Dawson, V. L., Dawson, T. M. & Snyder, S. H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687–689 (1994).
  Article CAS PubMed Google Scholar
• Eliasson, M. J. et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3, 1089–1095 (1997).
  Article CAS PubMed Google Scholar
• Endres, M., Wang, Z. -Q., Namura, S., Waeber, C. & Moskowitz, M. A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 17, 1143–1151 (1997).
  Article CAS PubMed Google Scholar
• Yuan, J. & Yanker, B. Y. Apoptosis in the nervous system. Nature 407, 802–809 (2000). A succinct summary of apoptotic cascades of cell death in neurological diseases.
  Article CAS PubMed Google Scholar
• Nicotera, P., Leist, M., Fava, E., Berliocchi, L. & Volbracht, C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 10, 276–282 (2000).
  Article CAS PubMed Google Scholar
• Yu, S. P. & Choi, D. W. Ions, cell volume, and apoptosis. Proc. Natl Acad. Sci. USA 97, 9360–9362 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, S. P., Yeh, C., Strasser, U., Tian, M. & Choi, D. W. NMDA receptor-mediated K+ efflux and neuronal apoptosis. Science 284, 336–339 (1999).
  Article CAS PubMed Google Scholar
• Nicotera, P. & Lipton, S. A. Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab. 19, 583–591 (1999).
  Article CAS PubMed Google Scholar
• Budd, S. L., Tenneti, L., Lishnak, T. & Lipton, S. A. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl Acad. Sci. USA 97, 6161–6666 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Martin-Villalba, A. et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809–3817 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Chopp, M., Chan, P. H., Hsu, C. Y., Cheung, M. E. & Jacobs, T. P. DNA damage and repair in central nervous system injury. Stroke 27, 363–369 (1996).
  Article CAS PubMed Google Scholar
• Salvesen, G. S. A lysosomal protease enters the death scene. J. Clin. Invest. 107, 21–22 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yamashina, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62, 273–295 (2000).
  Article Google Scholar
• Digicaylioglu, M. & Lipton, S. A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412, 641–647 (2001).
  Article CAS PubMed Google Scholar
• Mohr, S., Stamler, J. S. & Brune, B. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett. 348, 223–227 (1994).
  Article CAS PubMed Google Scholar
• Mannick, J. B. et al. Fas-induced caspase denitrosylation. Science 284, 651–654 (1999).
  Article CAS PubMed Google Scholar
• Elibol, B. et al. Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice. Neuroscience 105, 79–86 (2001).
  Article CAS PubMed Google Scholar
• Yu, S. -W. et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259–263 (2002). This study shows important organelle cross-talk linking mitochondrial dysfunction, energy deficits related to PARP activation and caspase-independent cell death mediated by AIF.
  Article CAS PubMed Google Scholar
• Schulz, J. B., Weller, M. & Moskowitz, M. A. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45, 421–429 (1999).
  Article CAS PubMed Google Scholar
• Namura, S. et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659–3668 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Wei, M. C. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727–730 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hara, H. et al. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl Acad. Sci. USA 94, 2007–2012 (1997). The first study demonstrating proof-of-concept that pharmacological inhibition of caspases protects brain in experimental stroke models.
  Article CAS PubMed PubMed Central Google Scholar
• Han, B. H. et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J. Biol. Chem. 277, 30128–30136 (2002).
  Article CAS PubMed Google Scholar
• Fink, K. et al. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18, 1071–1076 (1998).
  Article CAS PubMed Google Scholar
• Le, D. A. et al. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl Acad. Sci. USA 99, 15188–15193 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Graham, S. H. & Chen, J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 99–109 (2001). A comprehensive review surveying the evidence for multiple pathways of apoptotic-like cell death in stroke.
  Article CAS PubMed Google Scholar
• Qiu, J. et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci. 22, 3504–3511 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446 (1999).
  Article CAS PubMed Google Scholar
• Asoh, S. et al. Protection against ischemic brain injury by protein therapeutics. Proc. Natl Acad. Sci. USA 99, 17107–17112 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Fiskum, G. Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 17, 843–854 (2000).
  Article CAS PubMed Google Scholar
• Leist, M. & Jäättelä, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nature Rev. Mol. Cell Biol. 2, 1–10 (2001).
  Article CAS Google Scholar
• Petty, M. A. & Lo, E. H. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68, 311–323 (2002).
  Article CAS PubMed Google Scholar
• Cuzner, M. L. & Opdenakker, G. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94, 1–14 (1999).
  Article CAS PubMed Google Scholar
• Yong, V. W., Krekoski, C. A., Forsyth, P. A., Bell, R. & Edwards, D. R. Matrix metalloproteinases and disease of the CNS. Trends Neurosci. 21, 75–80 (1998).
  Article CAS PubMed Google Scholar
• Yong, V. W., Power, C., Forsyth, P. & Edwards, D. R. Metalloproteinases in biology and pathology of the nervous system. Nature Rev. Neurosci. 2, 502–511 (2001). An authoritative review describing the pathophysiologic roles of MMPs in CNS disorders.
  Article CAS Google Scholar
• Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. & Kaczmarek, L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22, 920–930 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Asahi, M. et al. Role of matrix metalloproteinase 9 in focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681–1690 (2000).
  Article CAS PubMed Google Scholar
• Gasche, Y. et al. Early appearance of activated MMP-9 after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 1020–1028 (1999).
  Article CAS PubMed Google Scholar
• Heo, J. H. et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624–633 (1999).
  Article CAS PubMed Google Scholar
• Rosenberg, G. A. & Navratil, M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48, 921–927 (1997).
  Article CAS PubMed Google Scholar
• Wang, X. et al. Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037–7043 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Clark, A. W., Krekoski, C. A., Bou, S. S., Chapman, K. R. & Edwards, D. R. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci. Lett. 238, 53–56 (1997).
  Article CAS PubMed Google Scholar
• Montaner, J. et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32, 1759–1766 (2001).
  Article CAS PubMed Google Scholar
• Wang, X., Mori, T., Jung, J. C., Fini, M. E. & Lo, E. H. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J. Neurotrauma 19, 615–625 (2002).
  Article PubMed Google Scholar
• Gasche, Y., Copin, J. C., Sugawara, T., Fujimura, M. & Chan P. H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 1393–1400 (2001).
  Article CAS PubMed Google Scholar
• Gu, Z. et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186–1190 (2002). Provides evidence that NOS nitrosylates MMPs and mediates anoikis-like cell death in neurons, thereby providing a link between nitrosative stress and extracellular proteolysis.
  Article CAS PubMed Google Scholar
• Anthony, D. C. et al. Matrix metalloproteinase expression in an experimentally induced DTH model of multiple sclerosis in rat CNS. J. Neuroimmunol. 87, 62–72 (1998).
  Article CAS PubMed Google Scholar
• Asahi, M. et al. Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724–7732 (2001). This study showed that deletion of the MMP9 gene protected against blood–brain barrier leakage and infarction after focal ischaemia, directly implicating this protease as a mediator of injury to the neurovascular unit.
  Article CAS PubMed PubMed Central Google Scholar
• Rosenberg, G. A., Estrada, E. Y. & Dencoff J. E. Matrix metalloproteinases and TIMPs are associated with blood–brain barrier opening after reperfusion in rat brain. Stroke 29, 2189–2195 (1998).
  Article CAS PubMed Google Scholar
• Asahi, M., Sumii, T., Fini, M. E., Itohara, S. & Lo, E. H. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 12, 3003–3007 (2001).
  Article CAS PubMed Google Scholar
• Pitman, R. N. & Beuttner, H. M. Degradation of extracellular matrix by neuronal proteases. Dev. Neurosci. 11, 361–375 (1989).
  Article Google Scholar
• Vivien, D. & Buisson, A. Serine protease inhibitors: novel therapeutic targets for stroke? J. Cereb. Blood Flow Metab. 20, 755–764 (2000).
  Article CAS PubMed Google Scholar
• Nagai, N. et al. Tissue type plasminogen activator is involved in the process of neuronal death by oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. 21, 631–634 (2001).
  Article CAS PubMed Google Scholar
• Nicole, O. et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Med. 7, 59–64 (2001).
  Article CAS PubMed Google Scholar
• Yepes, M. et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96, 569–576 (2000).
  Article CAS PubMed Google Scholar
• Wang, Y. F. et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nature Med. 4, 228–231 (1998). The first study to demonstrate that the thrombolytic agent tPA can directly exacerbate cerebral damage in stroke.
  Article CAS PubMed Google Scholar
• Tabrizi, P. et al. Tissue plasminogen activator deficiency exacerbates cerebrovascular fibrin deposition and brain injury. Arterioscler. Thromb. Vasc. Biol. 19, 2801–2806 (1999).
  Article CAS PubMed Google Scholar
• Ginsberg, M. D. On ischemic brain injury in genetically altered mice. Arterioscler. Thromb. Vasc. Biol. 19, 2581–2583 (1999).
  Article CAS PubMed Google Scholar
• Lo, E. H., Wang, X. & Cuzner, M. L. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J. Neurosci. Res. 69, 1–9 (2002).
  Article CAS PubMed Google Scholar
• Montaner, J. et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32, 2762–2767 (2001).
  Article CAS PubMed Google Scholar
• Aoki, T., Sumii, T., Mori, T., Wang, X. & Lo, E. H. Blood–brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33, 2711–2717 (2002).
  Article PubMed Google Scholar
• Sumii, T. & Lo, E. H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33, 831–836 (2002).
  Article CAS PubMed Google Scholar
• Lapchak, P. A., Chapman, D. F. & Zivin, J. A. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 31, 3034–3040 (2000). References 99 and 100 provide evidence that tPA can amplify MMP levels in stroke, and showed that an MMP inhibitor given with tPA reduces tPA-related haemorrhagic transformation in brain.
  Article CAS PubMed Google Scholar
• Tagaya, M. et al. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J. Cereb. Blood Flow Metab. 21, 835–846 (2001). This study showed that microvascular injury was related to neuronal cell death and therefore linked the response of these two cell components of the neurovascular unit.
  Article CAS PubMed Google Scholar
• Chen, Z. L. & Strickland, S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917–925 (1997).
  Article CAS PubMed Google Scholar
• Gary, D. & Mattson, M. P. Integrin signaling via the PI3-kinase–Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J. Neurochem. 76, 1485–1496 (2001).
  Article CAS PubMed Google Scholar
• Corley, S. M., Ladiwala, U., Besson, A. & Yong, V. W. Astrocytes attenuate oligodendrocyte death in vitro through an α6 integrin–laminin-dependent mechanism. Glia 36, 281–294 (2001).
  Article CAS PubMed Google Scholar
• Lee, S. & Lo, E. H. Induction of caspase-mediated cell death by matrix metalloproteinase after hypoxia–reoxygenation in human brain microvascular endothelial cells. Stroke 34, 250 (2003).
  Google Scholar
• McCawley, L. J. & Matrisian, L. M. Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534–540 (2001).
  Article CAS PubMed Google Scholar
• Ridker, P. M., Hennekens, C. H., Buring, J. E. & Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836–843 (2000).
  Article CAS PubMed Google Scholar
• Tanne, D. et al. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort. Stroke 33, 2182–2186 (2002).
  Article CAS PubMed Google Scholar
• Stanimirovich, D. & Satoh, K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol. 10, 113–126 (2000).
  Article Google Scholar
• Frijns, C. J. M. & Kappelle, L. J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33, 2115–2122 (2002).
  Article CAS PubMed Google Scholar
• Connolly, E. S. Jr et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209–216 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Connolly, E. S. Jr et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ. Res. 81, 304–310 (1997).
  Article CAS PubMed Google Scholar
• Del Zoppo, G. J. et al. Inflammation and stroke: putative role for cytokines, adhesion molecules, and iNOS in brain response to ischemia. Brain Pathol. 10, 95–112 (2000).
  Article CAS PubMed Google Scholar
• Huang, J. et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285, 595–598 (1999).
  Article CAS PubMed Google Scholar
• Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57, 1428–1434 (2001).
• Furuya, K. et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32, 2665–2674 (2001). This study dissects the inflammatory complications from administering the anti-ICAM antibody, and offers a possible explanation for the failure of the Enlimomab Acute Stroke Trial.
  Article CAS PubMed Google Scholar
• Allan, S. M. & Rothwell, N. J. Cytokines and acute neurodegeneration. Nature Rev. Neurosci. 2, 734–744 (2001).
  Article CAS Google Scholar
• Barone, F. C. & Feuerstein, G. Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819–834 (1999). A comprehensive review of the multifaceted aspects of inflammation in cerebral ischaemia.
  Article CAS PubMed Google Scholar
• Hughes, P. M. et al. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 22, 308–317 (2002).
  Article CAS PubMed Google Scholar
• Iadecola, C. et al. Reduced susceptibility to ischemic brain injury and _N_-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 1294–1299 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Boutin, H. et al. Role of IL-1α and IL-1β in ischemic brain damage. J. Neurosci. 21, 5528–5534 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Schielke, G. P., Yang, G. Y., Shivers, B. D. & Betz, A. L. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18, 180–185 (1998).
  Article CAS PubMed Google Scholar
• Nawahiro, H., Martin, D. & Hallenbeck, J. M. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 778, 265–271 (1997).
  Article Google Scholar
• Bruce, A. J. et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2, 788–794 (1996).
  Article CAS PubMed Google Scholar
• Fontaine, V. et al. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22, RC216 (2002).
  Article PubMed PubMed Central Google Scholar
• Zhang, Z. G. et al. VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829–838 (2000). This study on VEGF provided evidence for an early detrimental role in blood–brain barrier leakage and a potentially beneficial angiogenic role in delayed recovery after stroke.
  Article CAS PubMed PubMed Central Google Scholar
• Rosenberg, G. A. Matrix metalloproteinases in neuroinflammation. Glia 39, 279–291 (2002).
  Article PubMed Google Scholar
• D'Ambrosio, A. L., Pinsky, D. J. & Connolly, E. S. The role of the complement cascade in ischemia-reperfusion injury: implications for neuroprotection. Mol. Med. 7, 367–382 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Qiong, Z. & McNamara, J. O. Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack. Neuron 36, 363–374 (2002).
  Article Google Scholar
• Hacke, W. et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53, S3–S15 (1999).
  Article CAS PubMed Google Scholar
• Garcia, J. H., Liu, K. F. & Ho, K. L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26, 636–642 (1995).
  Article CAS PubMed Google Scholar
• Furlan, A. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282, 2003–2011 (1999).
  Article CAS PubMed Google Scholar
• Baron, J. -C. Mapping the ischaemic penumbra with PET: a new approach. Brain 124, 2–4 (2001).
  Article CAS PubMed Google Scholar
• Heiss, W. -D. et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 124, 20–29 (2001). A quantitative imaging study that defines ratios of penumbra and core in stroke patients.
  Article CAS PubMed Google Scholar
• Baird, A. E. & Warach, S. Magnetic resonance imaging of acute stroke. J. Cereb. Blood Flow Metab. 18, 583–609 (1998).
  Article CAS PubMed Google Scholar
• Asahi, M., Asahi, K., Wang, X. & Lo, E. H. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 20, 452–457 (2000).
  Article CAS PubMed Google Scholar
• Meden, P., Overgaard, K., Sereghy, T. & Boysen, G. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model. J. Neurol. Sci. 119, 209–216 (1993).
  Article CAS PubMed Google Scholar
• Zivin, J. A. & Mazzarella, V. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch. Neurol. 48, 1235–1238 (1991).
  Article CAS PubMed Google Scholar
• Andersen, M., Overgaard, K., Meden, P., Boysen, G. & Choi, S. C. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke 30, 1464–1471 (1999).
  Article CAS PubMed Google Scholar
• Yang, Y., Li, Q. & Shuaib, A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 39, 881–888 (2000).
  Article CAS PubMed Google Scholar
• Bowes, M. P., Rothlein, R., Fagan, S. C. & Zivin, J. A. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45, 815–819 (1995).
  Article CAS PubMed Google Scholar
• Shuaib, A., Yang, Y., Nakada, M. T., Li, Q. & Yang, T. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab')2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy. J. Cereb. Blood Flow Metab. 22, 215–222 (2002).
  Article CAS PubMed Google Scholar
• Lyden, P. et al. for the CLASS IHT Investigators. The Clomethiazole Acute Stroke Study in Tissue-Type Plasminogen Activator-Treated Stroke (CLASS-T): final results. Neurology 57, 1199–1205 (2001).
  Article CAS PubMed Google Scholar
• Grotta, J. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole. Cerebrovasc. Dis. 12, 258–263 (2001).
  Article CAS PubMed Google Scholar
• Schmid-Elsaesser, R., Hungerhuber, E., Zausinger, S., Baethmann, A. & Reulen, H. J. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. Stroke 30, 1891–1899 (1999).
  Article CAS PubMed Google Scholar
• Singhal, A. B., Dijkhuizen, R. M., Rosen, B. R. & Lo, E. H. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 58, 945–952 (2002).
  Article PubMed Google Scholar
• Nogawa, S. et al. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc. Natl Acad. Sci. USA 95, 10966–10971 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lyden, P. D., Jackson-Friedman, C., Shin, C. & Hassid, S. Synergistic combinatorial stroke therapy: a quantal bioassay of a GABA agonist and a glutamate antagonist. Exp. Neurol. 163, 477–489 (2000).
  Article CAS PubMed Google Scholar
• Barth, A., Barth, L. & Newell, D. W. Combination therapy with MK-801 and α-phenyl-tert-butyl-nitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures. Exp. Neurol. 141, 330–336 (1996).
  Article CAS PubMed Google Scholar
• Onal, M. Z. et al. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke 28, 1060–1065 (1997).
  Article CAS PubMed Google Scholar
• Du, C. et al. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 718, 233–236 (1996).
  Article CAS PubMed Google Scholar
• Ma, J., Endres, M. & Moskowitz, M. A. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br. J. Pharmacol. 124, 756–762 (1998). The first demonstration that anti-apoptosis agents can be combined with anti-excitotoxic therapies enhance benefit in experimental stroke.
  Article CAS PubMed PubMed Central Google Scholar
• Barth, A., Barth, L., Morrison, R. S. & Newell, D. W. bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro. Neuroreport 7, 1461–1464 (1996).
  Article CAS PubMed Google Scholar
• Schmid-Elsaesser, R., Hungerhuber, E., Zausinger, S., Baethmann, A. & Reulen, H. J. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia. Brain Res. 816, 471–479 (1999).
  Article CAS PubMed Google Scholar
• Schabitz, W. R. et al. Synergistic effects of a combination of low-dose bFGF and citicoline after temporary experimental focal ischemia. Stroke 30, 427–432 (1999).
  Article CAS PubMed Google Scholar
• Ma, J., Qiu, J., Hirt, L., Dalkara, T. & Moskowitz, M. A. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia. Br. J. Pharmacol. 133, 345–350 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• De Keyser, J., Sulter, G. & Luiten, P. G. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 22, 535–540 (2000).
  Article Google Scholar
• Gladstone, D. J., Black, S. E. & Hakim, A. M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33, 2123–2136 (2002).
  Article PubMed Google Scholar
• Kitagawa, K. et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528, 21–24 (1990).
  Article CAS PubMed Google Scholar
• Baxter, G. F. Ischaemic preconditioning of myocardium. Ann. Med. 29, 345–352 (1997).
  Article CAS PubMed Google Scholar
• Nandagopal, K., Dawson, T. M. & Dawson, V. L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J. Pharmacol. Exp. Ther. 297, 474–478 (2001).
  CAS PubMed Google Scholar
• Carroll, R. & Yellon, D. M. Myocardial adaptation to ischaemia: the preconditioning phenomenon. Int. J. Cardiol. 68, S93–S101 (1999).
  Article PubMed Google Scholar
• Moncayo, J., de Freitas, G. R., Bogousslavsky, J., Altieri, M. & van Melle, G. Do transient ischemic attacks have a neuroprotective effect? Neurology 54, 2089–2094 (2000).
  Article CAS PubMed Google Scholar
• Gonzalez-Zulueta, M. et al. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl Acad. Sci. USA 97, 436–441 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Impey, S., Obrietan, K. & Storm, D. R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11–14 (1999).
  Article CAS PubMed Google Scholar
• Inamasu, J. & Ichikizaki, K. Mild hypothermia in neurologic emergency: an update. Ann. Emerg. Med. 40, 220–230 (2002). A comprehensive review on the use of hypothermia in several neurological diseases.
  Article PubMed Google Scholar
• Busto, R. et al. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7, 729–738 (1987). The first demonstration that very small reductions in brain temperature profoundly protect against ischaemic injury, indicating that tissue survival was independent of lowered metabolic rate.
  Article CAS PubMed Google Scholar
• Minard, F. N. & Grant, D. S. Hypothermia as a mechanism for drug-induced resistance to hypoxia. Biochem. Pharmacol. 31, 1197–1203 (1982).
  Article CAS PubMed Google Scholar
• Markarian, G. Z., Lee, J. H., Stein, D. J. & Hong, S. -C. Mild hypothermia: therapeutic window after experimental cerebral ischemia. Neurosurgery 38, 542–551 (1996).
  CAS PubMed Google Scholar
• Welsh, F. A. & Harris, V. A. Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus. J. Cereb. Blood Flow Metab. 11, 617–620 (1991).
  Article CAS PubMed Google Scholar
• Ginsberg, M. D. in Primer on Cerebrovascular Diseases (eds Welch, K. M. A., Caplan, L. R., Reis, D. J. B., Siesjo, K. & Weir, B.) 272–275 (Academic, San Diego, 1997).
  Book Google Scholar
• Corbett, D., Hamilton, M. & Colbourne, F. Persistent neuroprotection with prolonged postischemic hypothermia in adult rats subjected to transient middle cerebral artery occlusion. Exper. Neurol. 163, 200–206 (2000).
  Article CAS Google Scholar
• The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 346, 549–556 (2002).
• Bernard, S. A. et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 346, 557–563 (2002). References 173 and 174 show that hypothermia can significantly improve neurological outcomes in patients suffering from transient global cerebral ischaemia.
  Article PubMed Google Scholar
• Shiozaki, T. et al. A multicenter prospective randomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. Mild Hypothermia Study Group in Japan. J. Neurosurg. 94, 50–54 (2001).
  Article CAS PubMed Google Scholar
• Schwab, S. et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29, 2461–2466 (1998).
  Article CAS PubMed Google Scholar
• Kammersgaard, L. P. et al. Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study: the Copenhagen Stroke Study. Stroke 31, 2251–2256 (2000).
  Article CAS PubMed Google Scholar
• Krieger, D. W. et al. Cooling for acute ischemic brain damage (COOL AID): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32, 1847–1854 (2001).
  Article CAS PubMed Google Scholar
• Colbourne, F., Sutherland, G. & Corbett, D. Postischemic hypothermia: a critical appraisal with implications for clinical treatment. Molec. Neurobiol. 14, 171–201 (1997).
  Article CAS Google Scholar
• Prosser, C. L. in Comparative Animal Physiology (ed. Prosser, C. L.) 362–428 (Saunders, Philadelphia, 1973).
  Google Scholar
• Ginsberg, M. D. & Busto, R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29, 529–534 (1998).
  Article CAS PubMed Google Scholar
• Azzimondi, G. et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke 26, 2040–2043 (1995).
  Article CAS PubMed Google Scholar
• Reith, J. et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347, 422–425 (1996).
  Article CAS PubMed Google Scholar
• Yamada, M. et al. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab. 20, 709–717 (2000).
  Article CAS PubMed Google Scholar
• Zhang, F., White, J. G. & Iadecola, C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 14, 217–226 (1994).
  Article CAS PubMed Google Scholar
• Morikawa, E. et al. L-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow and reduces infarction volume in the rat. Stroke 25, 429–435 (1994).
  Article CAS PubMed Google Scholar
• Laufs, U., LaFata, V., Plutzky, J. & Liao, K. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation 97, 1129–1135 (1998).
  Article CAS PubMed Google Scholar
• Endres, M. et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 95, 8880–8885 (1998). This study showed that statins protect brain from ischaemic injury by directly upregulating endogenous eNOS levels and improving blood flow.
  Article CAS PubMed PubMed Central Google Scholar
• Laufs, U. et al. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J. Clin. Invest. 106, 15–24 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7–22 (2002).
• Limbourg, F. P. et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 110, 1729–1738 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hafezi-Moghadam, A. et al. Cardiovascular protective effects of corticosteroids mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nature Med. 8, 473–479 (2002).
  Article CAS PubMed Google Scholar
• Hafezi-Moghadam, A. et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nature Med. 8, 473–479 (2002).
  Article CAS PubMed Google Scholar
• Chen, Z. et al. Estrogen receptor a mediates the nongenomic ativation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401–406 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• McCullough, L. D., Alkayed, N. J., Traystman, R. J., Williams, M. J., & Hurn, P. D. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32, 796–802 (2001).
  Article CAS PubMed Google Scholar
• Belayev, L. et al. Albumin therapy of transient focal cerebral ischemia. In vivo analysis of dynamic microvascular responses. Stroke 33, 1077–1084 (2002).
  Article PubMed Google Scholar
• Belayev, L., Liu, Y., Zhao, W., Busto, R. & Ginsberg, M. D. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32, 553–560 (2001).
  Article CAS PubMed Google Scholar
• Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 324, 71–86 (2002).
• Stapf, C. & Mohr, J. P. Ischemic stroke therapy. Ann. Rev. Med. 53, 453–475 (2002).
  Article CAS PubMed Google Scholar
• Becker, K. J. et al. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl Acad. Sci. USA 94, 10873–10878 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, H. et al. Induction of mucosal tolerance of E-selectin prevents ischemic and hemorrhagic stroke in spontaenously hypertensive genetically stroke-prone rats. Stroke 33, 2156–2164 (2002).
  Article CAS PubMed Google Scholar
• Stys, P. K. Anoxic and ischemic injury of myelinated axons in CNS white matter. J. Cereb. Blood Flow Metab. 18, 2–25 (1998).
  Article CAS PubMed Google Scholar
• Li, S., Mealing, G. A., Morley, P. & Stys, P. K. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na-dependent glutamate transport. J. Neurosci. 19, RC16 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Imai, H., Masayasu, H., Dewar, D., Graham, D. I. & Macrae, I. M. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32, 2149–2154 (2001).
  Article CAS PubMed Google Scholar
• Petty, M. A. & Wettstein, J. G. White matter ischemia. Brain Res. Rev. 31, 58–64 (1999).
  Article CAS PubMed Google Scholar
• Stys, P. K. & Jiang, Q. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci. Lett. 328, 150–154 (2002).
  Article CAS PubMed Google Scholar
• Irving, E. A., Bentley, D. L. & Parsons, A. A. Assessment of white matter injury following prolonged focal cerebral ischemia in rat. Acta Neuropathologica 102, 627–635 (2001).
  Article CAS PubMed Google Scholar
• McDonald, J. W., Althomsons, S. P., Hyra, K. L., Choi, D. W. & Goldberg, M. P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor mediated excitotoxicity. Nature Med. 4, 291–297 (1998). This study demonstrated that glutamate and AMPA receptor agonists are toxic to oligodendroglia, thereby implicating excitotoxicity in white matter strokes.
  Article CAS PubMed Google Scholar
• Matute, C., Alberdi, E., Ibarretxe, G. & Sanchez-Gomez, M. V. Excitotoxicity in glial cells. Eur. J. Pharmacol. 447, 239–246 (2002).
  Article CAS PubMed Google Scholar
• Gu, C., Casaccia, P., Srinivasan, A. & Chao, M. V. Oligodendrocyte apoptosis mediated by caspase activation. J. Neurosci. 19, 3043–3049 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Yin, X. et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18, 1953–1962 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Garbern, J. Y. et al. Patients lacking the major CNS myelin protein proteolipid 1 develop length dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125, 551–561 (2002).
  Article PubMed Google Scholar
• Chandler, S. et al. Matrix metalloproteinases degrade myelin basic protein. Neurosci. Lett. 201, 223–226 (1995).
  Article CAS PubMed Google Scholar
• Rosenberg, G. A., Sullivan, N. & Esiri, M. M. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32, 1162–1168 (2001).
  Article CAS PubMed Google Scholar
• Sharp, F. R., Massa, S. M. & Swanson, R. A. Heat-shock protein protection. Trends Neurosci. 22, 97–99 (1999).
  Article CAS PubMed Google Scholar
• Shimazaki, K., Ishida, A., & Kawai, N. Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci. Res. 20, 95–99 (1994).
  Article CAS PubMed Google Scholar
• Majda, B. T., Meloni, B. P., Rixon, N. & Knuckey, N. W. Suppression subtraction hybridization and northern analysis reveal upregulation of heat shock, trkB, and sodium calcium exchanger genes following global cerebral ischemia in the rat. Brain Res. Mol. Brain Res. 93, 173–179 (2001).
  Article CAS PubMed Google Scholar
• Sugawara, T., Noshita, N., Lewen, A., Kim, G. W. & Chan, P. H. Neuronal expression of the DNA repair protein Ku 70 after ischemic preconditioning corresponds to tolerance to global cerebral ischemia. Stroke 32, 2388–2393 (2001).
  Article CAS PubMed Google Scholar
• Ginis, I. et al. TNF-α-induced tolerance to ischemic injury involves differential control of NF-κB transactivation: the role of NF-κB association with p300 adaptor. J. Cereb. Blood Flow Metab. 22, 142–152 (2002).
  Article CAS PubMed Google Scholar
• Bernaudin, M. et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22, 393–403 (2002).
  Article CAS PubMed Google Scholar
• Dawson, T. M. Preconditioning-mediated neuroprotection through erythropoietin? Lancet 359, 96–97 (2002).
  Article PubMed Google Scholar
• Shamloo, M. & Wieloch, T. Changes in protein tyrosine phosphorylation in the rat brain after cerebral ischemia in a model of ischemic tolerance. J. Cereb. Blood Flow Metab. 19, 173–183 (1999).
  Article CAS PubMed Google Scholar
• Gu, Z., Jiang, Q. & Zhang, G. Extracellular signal-regulated kinase and c-Jun _N_-terminal protein kinase in ischemic tolerance. Neuroreport 12, 3487–3491 (2001).
  Article CAS PubMed Google Scholar
• Astrup, J., Sorensen, P. M. & Sorensen, H. R. Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital and lidocaine. Anesthesiology 55, 263–268 (1981).
  Article CAS PubMed Google Scholar
• Chopp, M. et al. The metabolic effects of mild hypothermia on global cerebral ischemia and recirculation in the cat: Comparison to normothermia and hyperthermia. J. Cereb. Blood Flow Metab. 9, 141–148 (1989).
  Article CAS PubMed Google Scholar
• Cardell, M., Boris-Moller, F. & Wieloch, T. Hypothermia prevents the ischemia-induced translocation and inhibition of protein kinase C in the rat striatum. J. Neurochem. 57, 1814–1817 (1991).
  Article CAS PubMed Google Scholar
• Maeda, T. et al. Mechanisms of excitatory amino acid release in contused brain tissue: effects of hypothermia and in situ administration of Co2+ on extracellular levels of glutamate. J. Neurotrauma 15, 655–664 (1998).
  Article CAS PubMed Google Scholar
• Globus, M. Y. -T., Busto, R., Lin, B., Schnippering, H. & Ginsberg, M. D. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J. Neurochem. 65, 1250–1256 (1995).
  Article CAS PubMed Google Scholar
• Mori, K. et al. Effects of mild (33 degrees C) and moderate (29 degrees C) hypothermia on cerebral blood flow and metabolism, lactate, and extracellular glutamate in experimental head injury. Neurol. Res. 20, 719–726 (1998).
  Article CAS PubMed Google Scholar
• Yenari, M. A. et al. Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J. Cereb. Blood Flow Metab. 22, 29–38 (2002).
  Article CAS PubMed Google Scholar
• Xu, R. X. et al. Specific inhibition of apoptosis after cold-induced brain injury by moderate postinjury hypothermia. Neurosurgery 43, 107–114 (1998).
  Article CAS PubMed Google Scholar
• Dempsey, R. J. et al. Moderate hypothermia decreases postischemic edema development and leukotriene production. Neurosurgery 21, 177–181 (1987).
  Article CAS PubMed Google Scholar
• Kumar, K. & Evans, A. T. Effect of hypothermia on microglial reaction in ischemic brain. Neuroreport 8, 947–950 (1997).
  Article CAS PubMed Google Scholar
• Han, H. S., Qiao, Y., Karabiyikoglu, M., Giffard, R. G. & Yenari, M. A. Hypothermia might alter the inflammatory cell-associated inducible nitric oxide synthase (iNOS) and subsequent nitric oxide (NO) and peroxynitrite generation in experimental stroke and inflammation. J. Neurosci. 22, 3921–3928 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Chatzipanteli, K. et al. Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: biochemical and immunocytochemical studies. J. Cereb. Blood Flow Metab. 20, 531–542 (2000).
  Article CAS PubMed Google Scholar
• Dietrich, D. W. et al. The importance of brain temperature in alterations of the blood–brain barrier following cerebral ischemia. J. Neuropathol. Exp. Neurol. 49, 486–497 (1990).
  Article CAS PubMed Google Scholar
• Chen, Q., Chopp, M., Bodzin, G. & Chen, H. Temperature modulation of cerebral depolarization during focal cerebral ischemia in rats: correlation with ischemic injury. J. Cereb. Blood Flow Metab. 13, 389–394 (1993).
  Article CAS PubMed Google Scholar
• Takemoto, M. & Liao, J. K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712–1719 (2001).
  Article CAS PubMed Google Scholar